Skip to main content

Advertisement

SpringerLink
Log in

Autoimmune Enteropathy: A Review and Update of Clinical Management

  • Small Intestine (J Sellin, Section Editor)
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Autoimmune enteropathy (AIE) is a rare condition characterized by intractable diarrhea, histologic changes on small intestinal biopsy, and failed response to dietary manipulation that also may present with extraintestinal manifestations. In many patients, immunosuppressive therapies are necessary. Although AIE is more common in infants, adult involvement has also been documented. Much of what is known about AIE has been gathered from case reports and small case series; therefore, more research in this evolving field is needed. IPEX (immunodysregulation polyendocrinopathy enteropathy X-linked syndrome) and APECED (autoimmune phenomena, polyendocrinopathy, candidiasis, and ectodermal dystrophy) are systemic forms of AIE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Akram S, Murray JA, Pardi DS, et al. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol. 2007;5:1282–90. A relatively large experience with adult AIE.

  2. •• Montalto M, D'Onofrio F, Santoro L, et al. Autoimmune enteropathy in children and adults. Scand J Gastroenterol. 2009;44:1029–36. Thorough review of the most important aspects of AIE including epidemiology, pathophysiology, clinical features, histopathology, diagnosis, and treatment.

  3. Bishu S, Arsenescu V, Lee EY, et al. Autoimmune enteropathy with a CD8+ CD7- T-cell small bowel intraepithelial lymphocytosis: case report and literature review. BMC Gastroenterol. 2011;11:131.

    Article  PubMed  CAS  Google Scholar 

  4. Hartfield D, Turner J, Huynh H, et al. The role of histopathology in diagnosing protracted diarrhea of infancy. Fetal Pediatr Pathol. 2010;29:144–1457.

    Article  PubMed  Google Scholar 

  5. Unsworth DJ, Walker-Smith JA. Autoimmunity in diarrhoeal disease. J Pediatr Gastroenterol Nutr. 1985;4:375–80.

    Article  PubMed  CAS  Google Scholar 

  6. • Quiros BA, Sanz AE, Ordiz BE, Garrote Adrados JA, et al. From autoimmune enteropathy to the IPEX (immune dysfunction, polyendocrinopathy, enteropathy, X-linked) syndrome. Allergol Immunopathol. 2009;37:208–15. Discusses the pathophysiology of AIE as well as IPEX, FOXP3, and immune function including T regulatory cell involvement.

    Google Scholar 

  7. Hill SM, Milla PJ, Bottazzo GF, et al. Autoimmune enteropathy and colitis: is there a generalised autoimmune gut disorder? Gut. 1991;32:36–42.

    Article  PubMed  CAS  Google Scholar 

  8. Russo PA, Brochu P, Seidman EG, Roy CC, et al. Autoimmune enteropathy. Pediatr Dev Pathol. 1999;2:65–71.

    Article  PubMed  CAS  Google Scholar 

  9. Volta U, De Angelis GL, Granito A, et al. Autoimmune enteropathy and rheumatoid arthritis: a new association in the field of autoimmunity. Dig Liver Dis. 2006;38:926–9.

    Article  PubMed  CAS  Google Scholar 

  10. Lachaux A. Autoimmune enteropathy. Arch Pediatr. 1996;3:261–6.

    Article  PubMed  CAS  Google Scholar 

  11. Mais DD, Mulhall BP, Adolphson KR, Yamamoto K. Thymoma-associated autoimmune enteropathy. A report of two cases. Am J Clin Pathol. 1999;112:810–5.

    Google Scholar 

  12. Elwing JE, Clouse RE. Adult-onset autoimmune enteropathy in the setting of thymoma successfully treated with infliximab. Dig Dis Sci. 2005;50:928–32.

    Article  PubMed  Google Scholar 

  13. Wildin RS, Freitas A. IPEX and FOXP3: clinical and research perspectives. J Autoimmun. 2005;25(Suppl):56–62.

    Article  PubMed  CAS  Google Scholar 

  14. Moes N, Rieux-Laucat F, Begue B, et al. Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy. Gastroenterology. 2010;139:770–8.

    Article  PubMed  CAS  Google Scholar 

  15. Perheentupa J. APS-I/APECED: the clinical disease and therapy. Endocrinol Metabol Clin NA. 2002;31:295–320, vi.

  16. • Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome. Ann N Y Acad Sci. 2011;1246:77–91. Recent overview of the rare APECED syndrome.

  17. Veress B, Franzén L, Bodin L, Borch K, et al. Duodenal intraepithelial lymphocyte-count revisited. Scand J Gastroenterol. 2004;39:138–44.

    Article  PubMed  CAS  Google Scholar 

  18. León F, Olivencia P, Rodríguez-Pena R, et al. Clinical and immunological features of adult-onset generalized autoimmune gut disorder. Am J Gastroenterol. 2004;99:1563–71.

    Article  PubMed  Google Scholar 

  19. Gonzalez G, Castro FP, Berho M, Petras R, et al. Autoimmune enteropathy associated with cessation of interferon-alpha therapy in chronic hepatitis C. Dig Dis Sci. 2010;55:1490–3.

    Article  PubMed  Google Scholar 

  20. Patey-Mariaud de Serre N, Canioni D, Ganousse S, et al. Digestive histopathological presentation of IPEX syndrome. Mod Pathol. 2009;22:95–102.

  21. Unsworth J, Hutchins P, Mitchell J, et al. Flat small intestinal mucosa and autoantibodies against the gut epithelium. J Pediatr Gastroenterol Nutr. 1982;1:503–13.

    Article  PubMed  CAS  Google Scholar 

  22. Skogh T, Heuman R, Tagesson C. Anti-brush border antibodies (ABBA) in Crohn's disease. J Clin Lab Immunol. 1982;9:147–50.

    PubMed  CAS  Google Scholar 

  23. Martín-Villa JM, Camblor S, Costa R, Arnaiz -Villena et al. Gut epithelial cell autoantibodies in AIDS pathogenesis. Lancet 1993;342:380.

  24. Verpy E, Leibovici M, Zwaenepoel I, et al. A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C. Nature Gen. 2000;26:51–5.

    Article  CAS  Google Scholar 

  25. Biagi F, Bianchi PI, Trotta L, Corazza GR. Anti-goblet cell antibodies for the diagnosis of autoimmune enteropathy? Am J Gastroenterol. 2009;104:3112.

    Article  PubMed  CAS  Google Scholar 

  26. Colletti RB, Guillot AP, Rosen S, et al. Autoimmune enteropathy and nephropathy with circulating anti-epithelial cell antibodies. J Pediatr. 1991;118:858–64.

    Article  PubMed  CAS  Google Scholar 

  27. Kobayashi I, Imamura K, Yamada M, et al. A 75-kD autoantigen recognized by sera from patients with X-linked autoimmune enteropathy associated with nephropathy. Clin Exper Immunol. 1998;111:527–31.

    Article  CAS  Google Scholar 

  28. Bitner-Glindzicz M, Lindley KJ, Rutland P, et al. A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nature Gen. 2000;26:56–60.

    Article  CAS  Google Scholar 

  29. Kobayashi I, Kubota M, Yamada M, et al. Autoantibodies to villin occur frequently in IPEX, a severe immune dysregulation, syndrome caused by mutation of FOXP3. Clin Immunol. 2011;141:83–9.

    Article  PubMed  CAS  Google Scholar 

  30. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–61.

    Article  PubMed  CAS  Google Scholar 

  31. Hashimura Y, Nozu K, Kanegane H, et al. Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Pediatric Nephrol. 2009;24:1181–6.

    Article  Google Scholar 

  32. Sanderson IR, Phillips AD, Spencer J, Walker-Smith JA, et al. Response to autoimmune enteropathy to cyclosporin A therapy. Gut. 1991;32:1421–5.

    Article  PubMed  CAS  Google Scholar 

  33. Ranta A, Mokanahalli R. Cerebral venous thrombosis in autoimmune enteropathy. New Zeal Med J. 2010;123:108–10.

    PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part through NIH Grant DK57892.

Dr. Thomas C Smyrk, MD, Department of Pathology, Mayo Clinic, College of Medicine for providing Figs. 1 and 2.

Disclosure

Dr. J. Murray has received grant support from the NIH and Alba Therapeutics, and consulting fees or honoraria from Ironwood, Inc., Flamenteras, Actogenix, Bayer Healthcare, Vysera Biomedical, 2G Pharma, Inc., ImmunosanT, Inc., and Shire US Inc. No other potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 55905, USA

    Nicole M. Gentile, Joseph A. Murray & Darrell S. Pardi

  2. Department of Internal Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 55905, USA

    Nicole M. Gentile

  3. Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 55905, USA

    Joseph A. Murray

Authors
  1. Nicole M. Gentile
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph A. Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Darrell S. Pardi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Darrell S. Pardi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gentile, N.M., Murray, J.A. & Pardi, D.S. Autoimmune Enteropathy: A Review and Update of Clinical Management. Curr Gastroenterol Rep 14, 380–385 (2012). https://doi.org/10.1007/s11894-012-0276-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-012-0276-2

Keywords

Search

Navigation